{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:24:43Z","timestamp":1790814283351,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Congenital hypothyroidism (CH) is one of the most common endocrine diseases in childhood. A significant proportion of CH cases are transient, but the risk factors for permanent CH (PCH) are not yet well established. The current guidelines suggest using levothyroxine until the age of 3\u2009years, but some studies suggest the possibility of earlier discontinuation. However, few, if any, studies have followed up on the results of early discontinuation. This study aimed to identify predictive factors of transient CH among infants with CH. We also investigated the results in patients who underwent a trial of early discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We gathered data regarding infants diagnosed with CH between July 2005 and July 2015 by retrospective chart review. Those with aplastic, hypoplastic or ectopic glands on thyroid ultrasonography or scan were excluded. Among them, early discontinuation subgroup was defined as those who discontinued levothyroxine before 30\u2009months of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From the 80 infants (40 males, 40 females) enrolled in this study, 51 were preterm. Nine (11.3%) were diagnosed with PCH. Compared with transient cases, those with PCH were on higher levothyroxine dose at discontinuation (4.3 vs 2.9\u2009\u03bcg\/kg,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). There was no difference in the proportion of permanent cases between preterm and full-term groups. In preterm group,infants with PCH required higher levothyroxine dose at discontinuation than those with transient CH (3.8 vs 2.5\u2009\u03bcg\/kg,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018). Levothyroxine discontinuation at a dose of 2.86\u2009\u03bcg\/kg could suggest PCH (sensitivity, 88.9%; specificity, 71.0%). Among the 9 patients who underwent a trial of early discontinuation, 8 successfully discontinued levothyroxine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The majority of CH patients discontinued levothyroxine successfully, including those who underwent a trial of early discontinuation. Higher levothyroxine dose at the time of discontinuation was found to be a predictive factor for PCH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-019-1833-8","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T01:23:20Z","timestamp":1574385800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism"],"prefix":"10.1186","volume":"19","author":[{"given":"Eun Sil","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8317-1192","authenticated-orcid":false,"given":"Ju Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"1833_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/adc.2010.190280","volume":"96","author":"SD Grosse","year":"2011","unstructured":"Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child. 2011;96:374\u20139.","journal-title":"Arch Dis Child"},{"key":"1833_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2431-10-9","volume":"10","author":"AR Kemper","year":"2010","unstructured":"Kemper AR, Ouyang L, Grosse SD. Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data. BMC Pediatr. 2010;10:9.","journal-title":"BMC Pediatr"},{"key":"1833_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2009.09.008","volume":"315","author":"S Horn","year":"2010","unstructured":"Horn S, Heuer H. Thyroid hormone action during brain development: more questions than answers. Mol Cell Endocrinol. 2010;315:19\u201326.","journal-title":"Mol Cell Endocrinol"},{"key":"1833_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/adc.2007.120618","volume":"93","author":"JH Jones","year":"2008","unstructured":"Jones JH, Gell\u00e9n B, Paterson WF, Beaton S, Donaldson MD. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth. Arch Dis Child. 2008;93:940\u20134.","journal-title":"Arch Dis Child"},{"key":"1833_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2265.2005.02239.x","volume":"62","author":"R Gaudino","year":"2005","unstructured":"Gaudino R, Garel C, Czernichow P, L\u00e9ger J. Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf). 2005;62:444\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1833_CR6","first-page":"154","volume":"10","author":"SY Hong","year":"2005","unstructured":"Hong SY, Chung HR, Lee SY, Shin CH, Yang SW. Factors distinguishing between transient and permanent hypothyroidism in patients diagnosed as congenital hypothyroidism by newborn screening. J Korean Soc Pediatr Endocrinol. 2005;10:154\u201360.","journal-title":"J Korean Soc Pediatr Endocrinol"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.6065\/apem.2017.22.2.115","volume":"22","author":"IS Park","year":"2017","unstructured":"Park IS, Yoon JS, So CH, Lee HS, Hwang JS. Predictors of transient congenital hypothyroidism in children with eutopic thyroid gland. Ann Pediatr Endocrinol Metab. 2017;22:115\u20138.","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"1833_CR8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1210\/jc.2012-3174","volume":"98","author":"S Rabbiosi","year":"2013","unstructured":"Rabbiosi S, Vigone MC, Cortinovis F, Zamproni I, Fugazzola L, Persani L, et al. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab. 2013;98:1395\u2013402.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1833_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.6065\/apem.2014.19.3.141","volume":"19","author":"Min Sun Cho","year":"2014","unstructured":"Cho MS, Cho GS, Park SH, Jung MH, Suh BK, Koh DGEarlier re-evaluation may be possible in pediatric patients with eutopic congenital hypothyroidism requiring lower L-thyroxine doses. Ann Pediatr Endocrinol Metab 2014;19:141\u2013145.","journal-title":"Annals of Pediatric Endocrinology & Metabolism"},{"key":"1833_CR10","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1111\/apa.12450","volume":"103","author":"G Lim","year":"2014","unstructured":"Lim G, Lee YK, Han HS. Early discontinuation of thyroxine therapy is possible in most very low-birthweight infants with hypothyroidism detected by screening. Acta Paediatr. 2014;103:e123\u20139.","journal-title":"Acta Paediatr"},{"key":"1833_CR11","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1542\/peds.2006-0915","volume":"117","author":"SR Rose","year":"2006","unstructured":"American Academy of Pediatrics, Rose SR, Section on Endocrinology and Committee on Genetics, Amerizan Thyroid Association, Brown RS, Public Health Committee, Lawson Wilkins Pediatrics Endocrine Society, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117:2290\u2013303.","journal-title":"Pediatrics"},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000435811","volume":"84","author":"MF Messina","year":"2015","unstructured":"Messina MF, Aversa T, Salzano G, Zirilli G, Sferlazzas C, De Luca F, et al. Early discrimination between transient and permanent congenital hypothyroidism in children with Eutopic gland. Horm Res Paediatr. 2015;84:159\u201364.","journal-title":"Horm Res Paediatr"},{"key":"1833_CR13","first-page":"699","volume":"18","author":"M Ghasemi","year":"2013","unstructured":"Ghasemi M, Hashemipour M, Hovsepian S, Heiydari K, Sajadi A, Hadian R, et al. Prevalence of transient congenital hypothyroidism in central part of Iran. J Res Med Sci. 2013;18:699\u2013703.","journal-title":"J Res Med Sci"},{"key":"1833_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jpeds.2004.02.020","volume":"144","author":"EA Eugster","year":"2004","unstructured":"Eugster EA, LeMay D, Zerin JM, Pescovitz OH. Definitive diagnosis in children with congenital hypothyroidism. J Pediatr. 2004;144:643\u20137.","journal-title":"J Pediatr"},{"key":"1833_CR15","first-page":"50","volume":"11","author":"HK Lim","year":"2006","unstructured":"Lim HK, Kim KH, Kim SH, No HY, Kim CJ, Woo YJ, et al. Predictors of transient hypothyroidism in neonatal screening test. J Korean Soc Pediatr Endocrinol. 2006;11:50\u20136.","journal-title":"J Korean Soc Pediatr Endocrinol."},{"key":"1833_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3346\/jkms.2009.24.4.627","volume":"24","author":"HR Chung","year":"2009","unstructured":"Chung HR, Shin CH, Yang SW, Choi CW, Kim BI, Kim EK, et al. High incidence of thyroid dysfunction in preterm infants. J Korean Med Sci. 2009;24:627\u201331.","journal-title":"J Korean Med Sci"},{"key":"1833_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0022-3476(78)80379-5","volume":"92","author":"S Uhrmann","year":"1978","unstructured":"Uhrmann S, Marks KH, Maisels MJ, Friedman Z, Murray F, Kulin HE, et al. Thyroid function in the preterm infant: a longitudinal assessment. J Pediatr. 1978;92:968\u201373.","journal-title":"J Pediatr"},{"key":"1833_CR18","first-page":"453","volume":"18","author":"N Skordis","year":"2005","unstructured":"Skordis N, Toumba M, Savva SC, Erakleous E, Topouzi M, Vogazianos M, et al. High prevalence of congenital hypothyroidism in the Greek Cypriot population: results of the neonatal screening program 1990-2000. J Pediatr Endocrinol Metab. 2005;18:453\u201361.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1833_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4274\/Jcrpe.931","volume":"5","author":"T Un\u00fcvar","year":"2013","unstructured":"Un\u00fcvar T, Demir K, Abac\u0131 A, B\u00fcy\u00fckgebiz A, B\u00f6ber E. The role of initial clinical and laboratory findings in infants with hyperthyrotropinemia to predict transient or permanent hypothyroidism. J Clin Res Pediatr Endocrinol. 2013;5:170\u20133.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1833_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.6065\/apem.2019.24.1.15","volume":"24","author":"HR Chung","year":"2019","unstructured":"Chung HR. Screening and management of thyroid dysfunction in preterm infants. Ann Pediatr Endocrinol Metab. 2019;24:15\u201321.","journal-title":"Ann Pediatr Endocrinol Metab"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1833-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T19:15:28Z","timestamp":1605899728000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1833-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1833-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13435\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13435\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13435\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13435\/v3","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"1 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Gyeongsang National University Hospital (approval no. 2018\u201301-018). The need for informed consent was waived by the institutional review board due to the retrospective nature of the study, and that data were anonymized with randomly assigned case numbers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"453"}}